Fiction has been preparing us for an unseen, all knowing CEO for decades. Now technology could make it reality.

The newly formed biotech launches with five promising autoimmune candidates, $300 million in funding, and leadership from ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 29th: GDS Holdings Limited GDS: This data center operator from China has a Zacks Rank #1 ...

Africa is building a new vaccine future through strategic investments, skilled workforce development, and local manufacturing ...

List today: Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year ...

We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...

Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy ...

New research by Turkish scientists has found that Pfizer’s Covid-19 vaccine may be associated with subtle changes to the ...

GSK has moved to shore up its R&D pipeline with a strategic-level deal with China's Jiangsu Hengrui Pharma that spans a dozen drug candidates and could be worth up to $12.5 billion.

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics ...

This past weekend, I had the joy of escaping the city for a stay at the breathtaking Cleo Hotel, nestled along the shores of Lake Kivu, in western Rwanda. The journey from Kigali to Lake Kivu is ...